Briefing Papers Number 5, August 2008 | Page 5

Intellectual Property Rights The U.S. commitment to development as it relates to migration depends on the work of more than one government agency, since USAID does not have the capacity or jurisdiction to address all migration topics. The United States needs cooperation among the Departments of Treasury, Commerce, Homeland Security, and other agencies. Coordinating these bureaucracies is a real test of the U.S. commitment to development. • Strengthening temporary worker programs: Temporary “guest” workers are a flexible source of labor, helping to fill jobs when there is a shortage of U.S.-born workers willing to do the work. This arrangement could benefit both the United States and the workers’ countries of origin. Currently, however, there are too few “guest workers” slots available to the many low-skilled migrants seeking to work in the United States. www.bread.org – – 2007e – 2006 – 2005 – 2004 – 2003 – 2002 – 2001 – 2000 – 1999 – 1998 – 1997 – 1996 – 1995 – 1994 – 1993 – 1992 1991 1990 – In 2003, President Bush announced a new plan to fight HIV/AIDS. The President’s Emergency Plan for AIDS Relief (PEPFAR) currently provides life-saving treatment to some 1.73 million people.29 The success of PEPFAR and the strong bipartisan support for the program are signs of a strong U.S. commitment to providing developing countries with access to essential medicines. But the United States’ strict rules about intellectual property rights counteract these efforts to make life-saving drugs more accessible to lowincome people. With strong U.S. support, the WTO’s Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement put in place intellectual property rights on patents for medicines. Unfortunately, the patent protection mechanism that is part of TRIPS can increase drug prices.30 The cost of essential medicines often puts them out of reach for • Improving the efficiency and lowering the cost of people who live on less than $1 a day.31 The vast majority of remittances: Families in other countries could receive HIV-positive people in the developing world do not receive larger remittance flows if the cost of remittances antiretroviral (ARV) drugs through PEPFAR or any other was lowered. Transaction fees reduced the value program. TRIPS is too restrictive because it extends patents on medof remittances to Latin American countries by an 28 These transaction costs icines for 20 years; makes it difficult for developing countries estimated $4 billion in 2004. to copy drug formulations for generic production; and limrepresent lost opportunities for development. its countries’ ability to cheaply import essential medicines.32 • Creating incentives for return migration: The For countries such as Brazil, which as part of its national United States can support return migration of public health strategy provides citizens with free medicines, temporary workers by negotiating incentive packages including ARV therapy for HIV/AIDS, TRIPS regulations with developing countries. Such packages might can compromise national healthcare programming. include portable retirement accounts available to On the other hand, developed countries and the busiworkers after they return home. nesses they represent in trade negotiations argue that strong intellectual property rights rules are necessary to promote the research and development of new Remittance and Capital Flows to Developing Countries medications. Without TRIPS, drug companies might not be 375 – US$ billions sufficiently rewarded for their in325 – vestment in the research needed to create new medicines. TRIPS 275 – is thus essential to ensuring that Foreign Direct 225 – businesses continue to invest in Investment research. In addition, concerns Recorded Private debt and 175 – Remittances porfolio equity have been raised over the safety 125 – and quality of generic versions of Official patented medicines. Without ad75 – Development equate safeguards such as those Assistance 25 – provided by the Food and Drug -25 – Administration, generically produced medicines may be ineffective and even dangerous. Sources: Global Economic Prospects 2006: Economic Implications of Remittances and Migration (World Bank), Over the past decade, WTO World Development Indicators 2007, and Global Development Finance 2007. member countries have worked Bread for the World Institute  5